Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.

Journal of gastroenterology and hepatology - 1 Sept 2008

Andoh Akira, Tsujikawa Tomoyuki, Ban Hiromitsu, Hashimoto Takayoshi, Bamba Shigeki, Ogawa Atsuhiro, Sasaki Masaya, Saito Yasuharu, Fujiyama Yoshihide

Abstract excerpt

BACKGROUND AND AIM: There have been no reports on 6-thioguanine nucleotide (6-TGN) concentrations in Japanese patients with inflammatory bowel disease (IBD) undergoing azathioprine (AZA) or 6-mercaptopurine (6-MP) therapy. The aim of this study was to assess 6-TGN concentrations in Japanese IBD patients. METHODS: Eighty-three patients with Crohn's disease (n = 42) and ulcerative colitis (n = 41) were enrolled. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azathioprine
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Erythrocyte Count

Share to Leukocyte Count

Share to Mercaptopurine

Share to Remission Induction

Share to Thioguanine

Source

Identifiers

PMID: 18662197
DOI: 10.1111/j.1440-1746.2008.05419.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.PMID 18662197Read ↗

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.Semantic proximity Read ↗

A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).Semantic proximity Read ↗

Monitoring thiopurine metabolites in korean pediatric patients with inflammatory bowel disease.Semantic proximity Read ↗

Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.Semantic proximity Read ↗

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.Semantic proximity Read ↗

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.Semantic proximity Read ↗

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.Semantic proximity Read ↗

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel diseaseSemantic proximity Read ↗

Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.Semantic proximity Read ↗

Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.Semantic proximity Read ↗

Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.Semantic proximity Read ↗

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug MonitoringSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.